Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences
Madrigal Pharmaceuticals (NASDAQ: MDGL) will participate in three investor conference fireside chats in late November and early December 2025. Presentations and live webcasts are scheduled as follows: Jefferies Global Healthcare Conference in London on Nov 20, 2025 at 8:30 A.M. GMT (3:30 A.M. ET); Evercore Healthcare Conference on Dec 2, 2025 at 4:15 P.M. ET; and Piper Sandler Healthcare Conference on Dec 3, 2025 at 1:30 P.M. ET. All fireside chats will be webcast live and can be accessed via Madrigal’s Investor Relations Events page.
Madrigal Pharmaceuticals (NASDAQ: MDGL) parteciperà a tre conversazioni informali con investitori (fireside chats) tra fine novembre e inizio dicembre 2025. Le presentazioni e i webcast in diretta sono programmati come segue: Jefferies Global Healthcare Conference a Londra il 20 novembre 2025 alle ore 8:30 GMT (3:30 ET); Evercore Healthcare Conference il 2 dicembre 2025 alle ore 16:15 ET; e Piper Sandler Healthcare Conference il 3 dicembre 2025 alle ore 13:30 ET. Tutte le sessioni saranno trasmesse in diretta e accessibili tramite la pagina Eventi delle Relazioni con gli Investitori di Madrigal.
Madrigal Pharmaceuticals (NASDAQ: MDGL) participará en tres conversaciones informales con inversionistas (fireside chats) a finales de noviembre y principios de diciembre de 2025. Las presentaciones y transmisiones en vivo están programadas como sigue: Jefferies Global Healthcare Conference en Londres el 20 de noviembre de 2025 a las 8:30 A.M. GMT (3:30 A.M. ET); Evercore Healthcare Conference el 2 de diciembre de 2025 a las 4:15 P.M. ET; y Piper Sandler Healthcare Conference el 3 de diciembre de 2025 a la 1:30 P.M. ET. Todas las fireside chats se transmitirán en vivo y se pueden acceder a través de la página de Eventos de Relaciones con Inversionistas de Madrigal.
Madrigal Pharmaceuticals (NASDAQ: MDGL)는 2025년 11월 말과 12월 초에 세 차례의 투자자 콘퍼런스 파이어사이드 채팅에 참여합니다. 발표와 라이브 webcast는 다음과 같이 예정되어 있습니다: 제프리스 글로벌 헬스케어 컨퍼런스가 런던에서 2025년 11월 20일 오전 8시 30분 GMT(동부표준시 3:30 AM); 에버코어 헬스케어 컨퍼런스가 2025년 12월 2일 오후 4시 15분 ET; 파이퍼 샌들러 헬스케어 컨퍼런스가 2025년 12월 3일 오후 1시 30분 ET에 개최됩니다. 모든 파이어사이드 채팅은 라이브로 생중계되며 Madrigal의 투자자 관계 이벤트 페이지에서 접근할 수 있습니다.
Madrigal Pharmaceuticals (NASDAQ: MDGL) participera à trois conversations informelles avec les investisseurs (fireside chats) à la fin du mois de novembre et au début de décembre 2025. Les présentations et webcasts en direct sont prévus comme suit : Jefferies Global Healthcare Conference à Londres le 20 novembre 2025 à 8h30 GMT (3h30 ET) ; Evercore Healthcare Conference le 2 décembre 2025 à 16h15 ET ; et Piper Sandler Healthcare Conference le 3 décembre 2025 à 13h30 ET. Tous les fireside chats seront diffusés en direct et accessibles via la page Événements des Relations Investisseurs de Madrigal.
Madrigal Pharmaceuticals (NASDAQ: MDGL) wird an drei Investorengesprächen (Fireside Chats) Ende November/Anfang Dezember 2025 teilnehmen. Präsentationen und Live-Webcasts sind wie folgt geplant: Jefferies Global Healthcare Conference in London am 20. November 2025 um 8:30 Uhr GMT (3:30 Uhr ET); Evercore Healthcare Conference am 2. Dezember 2025 um 16:15 Uhr ET; und Piper Sandler Healthcare Conference am 3. Dezember 2025 um 13:30 Uhr ET. Alle Fireside Chats werden live übertragen und sind über Madrigals Investor Relations Events-Seite zugänglich.
شركة Madrigal للأدوية (ناسداك: MDGL) ستشارك في ثلاث جلسات حوارية غير رسمية مع المستثمرين (fireside chats) في أواخر نوفمبر وبداية ديسمبر 2025. العروض التقديمية والبثوث المباشرة مجدولـة كما يلي: مؤتمر Jefferies العالمي للرعاية الصحية في لندن يوم 20 نوفمبر 2025 الساعة 8:30 صباحاً بتوقيت GMT (3:30 صباحاً بتوقيت ET); مؤتمر Evercore للرعاية الصحية في 2 ديسمبر 2025 الساعة 4:15 مساءً بتوقيت ET; ومؤتمر Piper Sandler للرعاية الصحية في 3 ديسمبر 2025 الساعة 1:30 مساءً بتوقيت ET. ستُبث جميع جلسات fireside مباشرة ويمكن الوصول إليها عبر صفحة أحداث العلاقات مع المستثمرين بمادريغال.
- None.
- None.
CONSHOHOCKEN, Pa., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in fireside chats at three upcoming investor conferences:
Jefferies Global Healthcare Conference in London
Thursday, Nov. 20, 2025 at 8:30 A.M. GMT (3:30 A.M. ET)
The presentation will be webcast live and may be accessed here.
8th Annual Evercore Healthcare Conference
Tuesday, Dec. 2, 2025 at 4:15 P.M. ET
The presentation will be webcast live and may be accessed here.
Piper Sandler 37th Annual Healthcare Conference
Wednesday, Dec. 3, 2025 at 1:30 P.M. ET
The presentation will be webcast live and may be accessed here.
The fireside chats will be webcast live and can be accessed by visiting Madrigal’s Investor Relations Events page.
About Madrigal
Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a liver disease with high unmet medical need. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c). For more information, visit www.madrigalpharma.com.
Investor Contact
Tina Ventura, IR@madrigalpharma.com
Media Contact
Christopher Frates, media@madrigalpharma.com
FAQ
When will Madrigal (MDGL) present at the Jefferies Global Healthcare Conference?
How can investors watch Madrigal (MDGL) at the Evercore Healthcare Conference on Dec 2, 2025?
What time is Madrigal (MDGL) scheduled at the Piper Sandler Healthcare Conference on Dec 3, 2025?
Will Madrigal (MDGL) webcast all three conference presentations?
Where can I find the live webcasts and replays of Madrigal (MDGL) conference presentations?
